Your plan says you pay 30%. It sounds clear, even fair. You pay a share and the insurer pays the rest. But stop on that number for a second and ask the question almost nobody asks: thirty percent of what? For a lot of people, the honest answer is a price no one in the system actually pays. That includes the pharmacy, which buys the drug for less, and often your insurer too, which may get money back later. The only person paying a cut of the full sticker price is you.

This is the quiet math of prescription coinsurance. It's worth understanding because it hits hardest in the worst moments, when a new diagnosis comes with a new and expensive drug.

Copay vs. coinsurance: a fixed number vs. a moving target

A copay is a flat amount. You pay $10, or $45, whatever the drug costs behind the scenes. You can budget for it, and it feels like a price tag.

Coinsurance is a percentage of the drug's cost. Your share goes up and down with a number you never see. When that number is small, coinsurance barely registers. When it's big, as it often is for brand-name and specialty drugs, a percentage that looked modest on the benefits summary turns into hundreds of dollars at the counter.

Plans usually use copays for cheaper tiers and switch to coinsurance for the expensive ones. That isn't a coincidence. A percentage moves more of the cost onto you exactly where the costs are highest.

The denominator nobody shows you

Here's the part that surprises people. The cost your percentage is applied to is often based on the drug's list price or a negotiated price close to it. It is usually not the lower price that results after the deals the industry makes out of view.

On many brand-name drugs, pharmacy benefit managers negotiate rebates with manufacturers. That money flows back to the PBM and the plan after the sale. It doesn't come off the price at the counter. So the price your coinsurance is figured from can sit well above what the drug finally costs the plan. You pay your 30% of the higher number, and the discount goes somewhere else.

This isn't a conspiracy theory. Health policy researchers and federal regulators have described it openly, and it's one reason some states and federal proposals have looked at requiring patient cost-sharing to reflect rebates. But nothing on your receipt hints at it. You see a single total and assume it's the real price.

Why percentages get past our defenses

There's a reason this doesn't make people angry the way a $400 copay would. Percentages are hard to feel.

Behavioral scientists have long documented that people judge ratios badly when they can't see the base. In a well-known body of work on denominator neglect, people react to the size of the top number and underweight what it's divided by. "30%" feels like the same 30% whether it's taken from $20 or $2,000. The percentage stays fixed in your head while the dollars underneath it swing wildly.

There's also plain confusion, and you shouldn't feel embarrassed by it. A 2013 study in the Journal of Health Economics by George Loewenstein and colleagues found that only a small fraction of insured Americans could correctly answer basic questions about deductibles, copays, coinsurance, and out-of-pocket maximums. When so many people struggle with a concept, the problem is the design, not them.

Then there's the emotional piece. Coinsurance usually shows up alongside bad news: a new condition, a drug that matters, a doctor saying this one should work. Nobody wants to be the person haggling over the treatment that's supposed to help. That reluctance to look closely is very human, and it's exactly what makes an unseen denominator so expensive.

How coinsurance interacts with your deductible

One more layer. Many plans make you meet a deductible before coinsurance kicks in at all. Until then, you might pay the full negotiated price, which is again often close to list. Once you pass the deductible, you pay your percentage. After you hit your plan's out-of-pocket maximum, you typically pay nothing more for covered drugs that year.

So the same prescription can cost you three very different amounts over a single year, and the order you hit them in depends on when your plan year resets and what else you've spent on care. If you're on Medicare Part D, recent law added an annual cap on out-of-pocket drug spending, set around $2,000 and adjusted each year. There's also an optional payment plan that spreads those costs over monthly bills so you don't take one huge hit. Both are worth knowing about if you use an expensive drug.

When the percentage loses to the cash price

Here's the counterintuitive part. For some drugs, especially generics, 30% of an inflated claim price can be more than the pharmacy's plain cash price. Generic drugs are often cheap to acquire. The government's own benchmark, the CMS National Average Drug Acquisition Cost, or NADAC, tracks what pharmacies typically pay. For many common generics that's a few cents to a few dollars per unit.

If the claim price your coinsurance is calculated on is far above that, your 'share' can end up bigger than the whole fair price. Paying cash and skipping insurance for that fill can be cheaper. There's a trade-off: cash payments often won't count toward your deductible or out-of-pocket maximum, so if you expect to reach your maximum this year, running claims through insurance may still be the better long-term move. But you can only make that choice if you know both numbers.

For brand-name and specialty drugs, cash is rarely the answer. There, the useful moves are knowing the denominator, using the protections your plan has, and checking manufacturer programs.

Your next moves

  • Find your actual coinsurance rate, by tier. Pull up your plan's Summary of Benefits and Coverage or its formulary today. Find the tier your drug sits on and write down whether it's a copay or a percentage, plus any per-fill minimum or maximum. Some plans cap coinsurance at a set dollar amount per prescription, and that cap is easy to miss.
  • Ask the pharmacy for the total claim price, not just your share. Next time you fill, say: What's the full price on the claim before my portion? Divide what you paid by that number. If the result matches your coinsurance rate, you've found the denominator.
  • Compare that claim price to a fair benchmark. Look up your drug's NADAC per-unit price and multiply by your quantity. If your share alone beats the fair acquisition cost, ask the pharmacist what the cash price would be for that fill.
  • Check where you stand on your deductible and out-of-pocket maximum. Log into your insurer's portal and note how much you've spent this year. If you're close to the maximum, keep running claims through insurance. If you're far from it, a cheaper cash fill on a generic may make sense.
  • For an expensive brand, ask two questions before you pay. Ask your plan whether a coinsurance cap or (on Medicare) the monthly payment plan applies. Then check the manufacturer's site for a savings or assistance program, and confirm how your plan treats that help.

Seeing the number behind the percentage

Coinsurance only works on people who can't see what it's a percentage of. Once you know the base number, "you pay 30%" stops being a vague promise and becomes something you can check, question, and sometimes beat. That's the whole reason SnapRx exists. Snap your prescription label and it shows you the fair national-average cash price from CMS NADAC data, plus real pharmacies nearby you can call. You'll walk up to the counter knowing what the drug typically costs, and whether your share is reasonable. If you'd like that number before your next fill, you can try it at snaprx.lumenlabs.works.